FDA Drug Application (021346) for RISPERDAL CONSTA by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021346
Product Number001
FormINJECTABLE;INTRAMUSCULAR
Dosage25MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRISPERDAL CONSTA
Active IngredientRISPERIDONE

Active IngredientCount
List of drugs with Active Ingredient RISPERIDONE3


Back to FDA Applications sponsored by JANSSEN PHARMS